Human Survivin and Trypanosoma cruzi Calreticulin Act in Synergy against a Murine Melanoma In Vivo

Immune-based anti-tumor or anti-angiogenic therapies hold considerable promise for the treatment of cancer. The first approach seeks to activate tumor antigen-specific T lymphocytes while, the second, delays tumor growth by interfering with blood supply. Tumor Associated Antigens are often employed...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguilar-Guzmán, Lorena, Lobos-González, Lorena, Rosas, Carlos, Vallejos, Gerardo, Falcón, Cristián, Sosoniuk, Eduardo, Coddou, Francisca, Leyton, Lisette, Lemus, David, Quest, Andrew F. G., Ferreira, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995754/
https://www.ncbi.nlm.nih.gov/pubmed/24755644
http://dx.doi.org/10.1371/journal.pone.0095457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995754/
https://www.ncbi.nlm.nih.gov/pubmed/24755644
http://dx.doi.org/10.1371/journal.pone.0095457

Ejemplares similares